Xtl Biopharmaceuticals (XTLB) Inventory (2012 - 2014)
Xtl Biopharmaceuticals (XTLB) posted quarterly Inventory of $222000.0 for Q3 2014, down 45.72% year-on-year from $409000.0 in Q3 2013, and down 26.25% on a QoQ basis from $301000.0 in Q2 2014.
Xtl Biopharmaceuticals (XTLB) Inventory (2012 - 2014) Analysis & Trends
Xtl Biopharmaceuticals (XTLB) has reported Inventory for 3 consecutive years, with $222000.0 the latest figure, recorded in Q3 2014.
- Quarterly Inventory fell 45.72% year-over-year to $222000.0 in Q3 2014, while the trailing twelve-month figure through Sep 2014 was $222000.0 (down 45.72% YoY) and the FY2013 annual result came in at $302000.0, up 31.88% from the prior year.
- Inventory declined to $222000.0 in Q3 2014 per XTLB's latest filing, from $301000.0 in the prior quarter.
- Over the last five years, Inventory for XTLB reached as high as $409000.0 in Q3 2013 and fell as low as $152000.0 in Q3 2012.
- A 3-year average of $259700.0 and a median of $247000.0 in 2012 frame the typical range for Inventory.
- Annual changes were most pronounced in 2013 — Inventory jumped 169.08% — and 2014, when it slumped 45.72%.
- Year by year, Inventory stood at $229000.0 in 2012, then jumped by 31.88% to $302000.0 in 2013, then dropped by 26.49% to $222000.0 in 2014.
- According to Business Quant data, Inventory over the past three periods registered $222000.0, $301000.0, and $208000.0 for Q3 2014, Q2 2014, and Q1 2014 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 681.59 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.77 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.10 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 371.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Xtl Biopharmaceuticals | 2.60 Bn | 2.60 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | 222,000.00 |
| Jun 30, 2014 | 301,000.00 |
| Mar 31, 2014 | 208,000.00 |
| Dec 31, 2013 | 302,000.00 |
| Sep 30, 2013 | 409,000.00 |
| Jun 30, 2013 | 265,000.00 |
| Mar 31, 2013 | 323,000.00 |
| Dec 31, 2012 | 229,000.00 |
| Sep 30, 2012 | 152,000.00 |
| Jun 30, 2012 | 186,000.00 |